Yaribeygi, H.; Maleki, M.; Reiner, Ž.; Jamialahmadi, T.; Sahebkar, A.
Mechanistic View on the Effects of SGLT2 Inhibitors on Lipid Metabolism in Diabetic Milieu. J. Clin. Med. 2022, 11, 6544.
https://doi.org/10.3390/jcm11216544
AMA Style
Yaribeygi H, Maleki M, Reiner Ž, Jamialahmadi T, Sahebkar A.
Mechanistic View on the Effects of SGLT2 Inhibitors on Lipid Metabolism in Diabetic Milieu. Journal of Clinical Medicine. 2022; 11(21):6544.
https://doi.org/10.3390/jcm11216544
Chicago/Turabian Style
Yaribeygi, Habib, Mina Maleki, Željko Reiner, Tannaz Jamialahmadi, and Amirhossein Sahebkar.
2022. "Mechanistic View on the Effects of SGLT2 Inhibitors on Lipid Metabolism in Diabetic Milieu" Journal of Clinical Medicine 11, no. 21: 6544.
https://doi.org/10.3390/jcm11216544
APA Style
Yaribeygi, H., Maleki, M., Reiner, Ž., Jamialahmadi, T., & Sahebkar, A.
(2022). Mechanistic View on the Effects of SGLT2 Inhibitors on Lipid Metabolism in Diabetic Milieu. Journal of Clinical Medicine, 11(21), 6544.
https://doi.org/10.3390/jcm11216544